Steven Cohen’s NovoCure NVCR Stock Holding History

Steven Cohen’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2M	Sell	803,120 -558,271	-41%	-$8.45M	0.01%	1172
2026 Q1	$14.8M	Buy	1,361,391 +460,895	+51%	+$5.76M	0.02%	987
2025 Q4	$11.6M	Buy	900,496 +783,896	+672%	+$10.1M	0.01%	1261
2025 Q3	$1.51M	Sell	116,600 -353,400	-75%	-$4.72M	﹤0.01%	1559
2025 Q2	$8.37M	Buy	+470,000	New	+$8.19M	0.02%	802
2024 Q2	–	Sell	-32,600	Closed	-$510K	–	2282
2024 Q1	$510K	Sell	32,600 -335,800	-91%	-$4.94M	﹤0.01%	1645
2023 Q4	$5.5M	Buy	368,400 +356,856	+3,091%	+$4.78M	0.01%	880
2023 Q3	$186K	Sell	11,544 -13,289	-54%	-$383K	﹤0.01%	1784
2023 Q2	$1.03M	Buy	+24,833	New	+$1.54M	﹤0.01%	1137
2019 Q3	–	Sell	-8,126	Closed	-$514K	–	1366
2019 Q2	$514K	Sell	8,126 -437	-5%	-$22.1K	﹤0.01%	833
2019 Q1	$412K	Buy	+8,563	New	+$412K	﹤0.01%	886

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Steven Cohen's NVCR Position: Q2 2026 in Review

Steven Cohen reduced its NovoCure (NVCR) stake by 41% in Q2 2026, selling an estimated $8.45M and leaving 803,120 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #1172.

Steven Cohen first reported a position in NVCR in Q1 2019 and has held it in 11 quarters since. The position peaked at $14.8M in Q1 2026. 215 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Steven Cohen held 803,120 shares of NovoCure worth $12.2M as of Q2 2026.
Steven Cohen sold 558,271 NovoCure shares in Q2 2026, an estimated $8.45M.
NovoCure made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1172 holding.
Steven Cohen first reported a position in NovoCure in Q1 2019 and has held it in 11 quarters since.
Steven Cohen's NovoCure position peaked at $14.8M in Q1 2026.
215 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.